Malarial Parasites may Lay Hidden in the Bone Marrow to Escape Detection

People with malarial infections who are not sick could be transmitting the disease before they have symptoms as these parasites may accumulate in the bone marrow at first to escape detection, finds a new study,

Malarial parasites may hide in the bone marrow even before the symptoms of malaria are noticed so that they can start the infection when they are undetected, finds a new study. The findings of this study are published in mBio journal.

P. vivax is the malaria parasite responsible for the vast majority of infections outside sub-Saharan Africa. In the mBio study, an international team of researchers report that the parasite doesn't only circulate in the blood; it also takes up residence in the bone marrow.

Malaria - Causes, Symptoms, Diagnosis, Prevention, Treatment
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is characterized by fever, vomiting, shivering, sweating and other symptoms.

‘People who are asymptomatic (without symptoms) even when they have a malarial infection may transmit the disease to others. As the malarial parasite has been found to hide in the bone marrow to escape detection.’

Their analysis of P. vivax infections in people and non-human primates reveals bone marrow as an important -- and previously unstudied -- reservoir for parasite replication and transmission. People with infections who show no signs or symptoms may host undetected parasites in their marrow, the authors conclude, and the findings may help explain why many P. vivax infections go undetected.

"People with infections who are not sick are transmitting the disease before they have symptoms," says veterinarian Nicanor Obaldia III, who co-led the study with parasitologist Elamaran Meibalan, both at the Harvard T.H. Chan School of Public Health in Boston, Massachusetts. They and their collaborators showed that P. vivax gametocytes, cells that are essential for transmission, mature rapidly in the bone marrow and can be transmitted to mosquitoes before the onset of illness.

P. vivax was once considered a 'benign' malaria because it's often asymptomatic, it's characterized by low numbers of detectable parasites in the blood, and it's less lethal than its parasite cousin, P. falciparum, which causes 90 percent of malaria deaths worldwide. But P. vivax can cause severe and even fatal symptoms, and more than a third of the world's population is at risk. Tens of millions of people are infected annually, and the parasite poses a significant health care burden in many regions including Southeast Asia and South America.

Cell Invasion Mystery of Malarial Parasites Solved
The results could help improve the development of an effective malaria vaccine. Protein interaction between malarial parasite and human host cells has now been found. This revelation could improve the development of an effective malaria vaccine.

In the bone marrow, the parasite may remain undetectable by blood tests, and as a result, public health workers may not be able to accurately estimate the parasite burden, says senior author, Matthias Marti, at the Harvard T.H. Chan School of Public Health and at the University of Glasgow. "If there is a large reservoir in the bone marrow in the absence of detectable parasites in the blood, then you may underestimate the number of people that are able to transmit the disease," he says.

To find the hidden reservoir, the researchers first analyzed the transcriptome of P. vivax to identify blood-borne proteins that correspond to different stages of the life cycle of the parasite. Then, they analyzed blood samples from infected patients for the presence of these biomarkers. Those data showed that a significant fraction of P. vivax life stages were underrepresented in the blood, which suggested these stages can accumulate in some tissues in the body.

CRISPR/Cas9 Tool may Help Suppress Malarial Parasites in Mosquitoes
CRISPR/ Cas9, genome editing tool may help develop new strategies to prevent malaria transmission from mosquitoes.

"We suspected there was a parasite reservoir somewhere in the body, and nobody had found it yet," says Marti. But the bone marrow was suspect since P. vivax tends to attack young red blood cells that are formed in bone marrow tissue.

The team studied tissues from 13 infected non-human primate autopsies, including bone marrow, lung, liver, brain, intestine, and subcutaneous fat. They found few or no parasites in the latter three, but in the liver, bone marrow and lung they found antibodies against all stages of the parasite, including those depleted in the blood. Further studies found parasites in the liver and bone marrow outside of blood vessels, and the researchers estimate that parasites in those two tissues comprised 30 percent of the total parasite burden in the animals, in particular gametocytes.

Common Toiletry Antimicrobial Compound Prevents Malarial Spread
Triclosan, an antimicrobial compound used in toiletries can inhibit target genes in the malaria parasite during the hepatic stage and the erythrocytic stage of malarial parasite lifecycle in humans.

The new study reflects a growing interest in the tropical disease community to understand P. vivax. The researchers have now begun studying the pathogenesis of infection in the bone marrow and learn more about the biology of the parasite. In addition, Marti says the biomarkers used by the team to find the hidden reservoir could inform a new generation of diagnostic tools that can finger parasites that would otherwise go undetected -- and help public health officials get a better estimate of the disease burden.

With such tools, "we may be able to detect parasites in the marrow," Marti says. "The study opens up a new area of investigation."

Source-Eurekalert